402 related articles for article (PubMed ID: 37781096)
1. The role of glycogen synthase kinase 3 beta in neurodegenerative diseases.
Yu H; Xiong M; Zhang Z
Front Mol Neurosci; 2023; 16():1209703. PubMed ID: 37781096
[TBL] [Abstract][Full Text] [Related]
2. Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease.
Golpich M; Amini E; Hemmati F; Ibrahim NM; Rahmani B; Mohamed Z; Raymond AA; Dargahi L; Ghasemi R; Ahmadiani A
Pharmacol Res; 2015 Jul; 97():16-26. PubMed ID: 25829335
[TBL] [Abstract][Full Text] [Related]
3. Glycogen Synthase Kinase 3β Involvement in Neuroinflammation and Neurodegenerative Diseases.
Gianferrara T; Cescon E; Grieco I; Spalluto G; Federico S
Curr Med Chem; 2022; 29(27):4631-4697. PubMed ID: 35170406
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.
Islam MT
Neurol Res; 2017 Jan; 39(1):73-82. PubMed ID: 27809706
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Astrocytes and microRNA Dysregulation in Neurodegenerative Diseases: From Pathogenesis to Therapeutic Potential.
Bai Y; Su X; Piao L; Jin Z; Jin R
Front Mol Neurosci; 2021; 14():556215. PubMed ID: 33815055
[TBL] [Abstract][Full Text] [Related]
6. Association of glycogen synthase kinase-3β with Parkinson's disease (review).
Li DW; Liu ZQ; Chen W; Yao M; Li GR
Mol Med Rep; 2014 Jun; 9(6):2043-50. PubMed ID: 24681994
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
[TBL] [Abstract][Full Text] [Related]
8. Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: From chemistry to medicine.
Jin S; Zhang L; Wang L
Biomed Pharmacother; 2023 Sep; 165():115215. PubMed ID: 37494786
[TBL] [Abstract][Full Text] [Related]
9. ASK1 in neurodegeneration.
Guo X; Namekata K; Kimura A; Harada C; Harada T
Adv Biol Regul; 2017 Dec; 66():63-71. PubMed ID: 28882588
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases.
Gao J; Wang L; Liu J; Xie F; Su B; Wang X
Antioxidants (Basel); 2017 Apr; 6(2):. PubMed ID: 28379197
[TBL] [Abstract][Full Text] [Related]
11. The pivotal role of JAK/STAT and IRS/PI3K signaling pathways in neurodegenerative diseases: Mechanistic approaches to polyphenols and alkaloids.
Kooshki L; Zarneshan SN; Fakhri S; Moradi SZ; Echeverria J
Phytomedicine; 2023 Apr; 112():154686. PubMed ID: 36804755
[TBL] [Abstract][Full Text] [Related]
12. Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases.
Luo F; Sandhu AF; Rungratanawanich W; Williams GE; Akbar M; Zhou S; Song BJ; Wang X
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998479
[TBL] [Abstract][Full Text] [Related]
13. Oxytocin in Huntington's disease and the spectrum of amyotrophic lateral sclerosis-frontotemporal dementia.
Bergh S; Cheong RY; Petersén Å; Gabery S
Front Mol Neurosci; 2022; 15():984317. PubMed ID: 36187357
[TBL] [Abstract][Full Text] [Related]
14. New insights into glycogen synthase kinase-3: A common target for neurodegenerative diseases.
Wang C; Cui Y; Xu T; Zhou Y; Yang R; Wang T
Biochem Pharmacol; 2023 Dec; 218():115923. PubMed ID: 37981175
[TBL] [Abstract][Full Text] [Related]
15. Autophagy and apoptosis dysfunction in neurodegenerative disorders.
Ghavami S; Shojaei S; Yeganeh B; Ande SR; Jangamreddy JR; Mehrpour M; Christoffersson J; Chaabane W; Moghadam AR; Kashani HH; Hashemi M; Owji AA; Łos MJ
Prog Neurobiol; 2014 Jan; 112():24-49. PubMed ID: 24211851
[TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNAs: New Insights in Neurodegenerative Diseases.
Anilkumar AK; Vij P; Lopez S; Leslie SM; Doxtater K; Khan MM; Yallapu MM; Chauhan SC; Maestre GE; Tripathi MK
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396946
[TBL] [Abstract][Full Text] [Related]
17. Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders.
Gupta R; Advani D; Yadav D; Ambasta RK; Kumar P
Mol Neurobiol; 2023 Nov; 60(11):6476-6529. PubMed ID: 37458987
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial diseases of the brain.
Chaturvedi RK; Flint Beal M
Free Radic Biol Med; 2013 Oct; 63():1-29. PubMed ID: 23567191
[TBL] [Abstract][Full Text] [Related]
19. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial Medicine: A Promising Therapeutic Option Against Various Neurodegenerative Disorders.
Almikhlafi MA; Karami MM; Jana A; Alqurashi TM; Majrashi M; Alghamdi BS; Ashraf GM
Curr Neuropharmacol; 2023; 21(5):1165-1183. PubMed ID: 36043795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
